Advertisement
UK markets closed
  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.82 (+1.48%)
     
  • CRUDE OIL

    78.47
    +0.36 (+0.46%)
     
  • GOLD FUTURES

    2,304.30
    -4.30 (-0.19%)
     
  • DOW

    38,675.68
    +449.98 (+1.18%)
     
  • Bitcoin GBP

    51,084.01
    +154.57 (+0.30%)
     
  • CMC Crypto 200

    1,333.02
    +56.04 (+4.38%)
     
  • NASDAQ Composite

    16,156.33
    +315.33 (+1.99%)
     
  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

Availability of Transgene's 2023 Universal Registration Document

Transgene S.A.
Transgene S.A.

TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31, 2023, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.24-0274.

The 2023 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company’s website: www.transgene.fr, in the “Investors/Financial information” section and on the AMF website: www.amf-france.org.

It includes:

  • the 2023 annual financial report;

  • the report of the Board of Directors on corporate governance;

  • the statutory auditor’s reports;

  • information on the share buyback program;

  • information related on the auditor’s fees.

ADVERTISEMENT

The universal registration document also includes information on the Company’s environmental and social responsibility.

Contacts

Transgene:
Lucie Larguier
Chief Financial Officer
+33 (0)3 88 27 91 04
investorrelations@transgene.fr

 

Attachment